| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |